CIK: 0001425738 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $1,357,911 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DBVT | DBV TECHNOLOGIES S A | 549,840 | $10,540 | 0.8% | $19.17 | — | SPONSORED ADS | 23306J309 |
| XENE | XENON PHARMACEUTICALS INC | 133,882 | $6,001 | 0.4% | $42.00 | 0.0% | COM | 98420N105 |
| ORIC | ORIC PHARMACEUTICALS INC | 448,110 | $3,666 | 0.3% | $11.51 | 0.0% | COM | 68622P109 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NRIX | NURIX THERAPEUTICS INC | 8,093,908 (+120.0%) | $153,541 (+351.7%) | 11.3% | $17.18 | -16.4% | COM | 67080M103 |
| SRRK | SCHOLAR ROCK HLDG CORP | 5,220,846 (+33.7%) | $229,978 (+58.2%) | 16.9% | $18.57 | +102.0% | COM | 80706P103 |
| IMNM | IMMUNOME INC | 5,718,385 (+13.8%) | $122,831 (+108.8%) | 9.0% | $11.49 | +52.8% | COM | 45257U108 |
| KRYS | KRYSTAL BIOTECH INC | 677,705 (+2.5%) | $167,081 (+43.1%) | 12.3% | $62.38 | +237.4% | COM | 501147102 |
| ANNX | ANNEXON INC | 10,050,644 (+59.5%) | $50,454 (+162.6%) | 3.7% | $9.79 | -61.0% | COM | 03589W102 |
| NUVB | NUVATION BIO INC | 3,163,256 (+4.4%) | $28,343 (+152.7%) | 2.1% | $10.97 | -43.5% | COM CL A | 67080N101 |
| RAPT | RAPT THERAPEUTICS INC | 885,927 (+60.3%) | $30,006 (+110.6%) | 2.2% | $16.44 | +88.9% | COM NEW | 75382E208 |
| REPL | REPLIMUNE GROUP INC | 1,099,756 (+105.2%) | $10,690 (+376.1%) | 0.8% | $12.40 | -31.5% | COM | 76029N106 |
| NGNE | NEUROGENE INC | 1,459,599 (+12.4%) | $30,068 (+33.6%) | 2.2% | $22.00 | +13.1% | COM | 64135M105 |
| IVVD | INVIVYD INC | 2,681,159 (+17.3%) | $6,622 (+163.4%) | 0.5% | $16.17 | -87.1% | COM | 00534A102 |
| PLRX | PLIANT THERAPEUTICS INC | 1,616,228 (+1.5%) | $1,972 (-16.3%) | 0.1% | $22.50 | -93.3% | COM | 729139105 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | AKERO THERAPEUTICS INC | 747,818 | $35,506 | 2.6% | $33.38 | — | — | 00973Y108 |
| — | 89BIO INC | 1,473,136 | $21,655 | 1.6% | $11.28 | — | — | 282559103 |
| KROS | KEROS THERAPEUTICS INC | 552,506 | $8,741 | 0.6% | $59.30 | -70.4% | — | 492327101 |
| FOLD | AMICUS THERAPEUTICS INC | 777,178 | $6,124 | 0.5% | $10.35 | -5.1% | — | 03152W109 |
| XERS | XERIS BIOPHARMA HOLDINGS INC | 451,099 | $3,672 | 0.3% | $2.16 | +264.4% | — | 98422E103 |
| VTYX | VENTYX BIOSCIENCES INC | 1,073,386 | $3,338 | 0.2% | $2.09 | +257.9% | — | 92332V107 |
| — | LAVA THERAPEUTICS NV | 2,074,372 | $3,236 | 0.2% | $15.19 | — | — | N51517105 |
| PRME | PRIME MEDICINE INC | 87,118 | $483 | 0.0% | $14.27 | -68.8% | — | 74168J101 |
| BOLD | BOUNDLESS BIO INC | 245,458 | $302 | 0.0% | $14.25 | -91.3% | — | 10170A100 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ZYME | ZYMEWORKS INC | 491,654 (-86.7%) | $12,945 (-79.5%) | 1.0% | $7.05 | +209.5% | COM | 98985Y108 |
| LIVN | LIVANOVA PLC | 118,054 (-87.3%) | $7,264 (-85.0%) | 0.5% | $70.40 | -18.8% | SHS | G5509L101 |
| STOK | STOKE THERAPEUTICS INC | 4,034,070 (-3.4%) | $128,041 (+30.5%) | 9.4% | $9.00 | +234.1% | COM | 86150R107 |
| COGT | COGENT BIOSCIENCES INC | 1,437,918 (-34.9%) | $51,075 (+61.0%) | 3.8% | $9.95 | +182.5% | COM | 19240Q201 |
| RGNX | REGENXBIO INC | 4,368,804 (-6.9%) | $62,911 (+38.9%) | 4.6% | $22.74 | -45.2% | COM | 75901B107 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 112,664 (-12.9%) | $8,211 (+54.8%) | 0.6% | $44.21 | +36.6% | COM | G31249108 |
| ALXO | ALX ONCOLOGY HLDGS INC | 3,264,718 (-2.0%) | $3,689 (-39.5%) | 0.3% | $15.46 | -90.2% | COM | 00166B105 |
| BEAM | BEAM THERAPEUTICS INC | 1,285,859 (-7.3%) | $35,644 (+5.8%) | 2.6% | $26.47 | -3.6% | COM | 07373V105 |
| SLDB | SOLID BIOSCIENCES INC | 1,860,542 (-2.0%) | $10,493 (-10.5%) | 0.8% | $4.65 | +16.5% | COM NEW | 83422E204 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 283,308 (-13.4%) | $7,695 (-9.0%) | 0.6% | $11.60 | +127.1% | COM NEW | 15117B202 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ADCT | ADC THERAPEUTICS SA | 15,666,731 | $55,304 | 4.1% | $19.52 | -79.2% | SHS | H0036K147 |
| STTK | SHATTUCK LABS INC | 5,539,724 | $20,220 | 1.5% | $32.14 | -92.6% | COM | 82024L103 |
| IDYA | IDEAYA BIOSCIENCES INC | 742,017 | $25,652 | 1.9% | $27.49 | +16.0% | COM | 45166A102 |
| CBLL | CERIBELL INC | 435,239 | $9,545 | 0.7% | $27.25 | -43.0% | COM | 15678C102 |
| ABSI | ABSCI CORPORATION | 8,253,316 | $28,804 | 2.1% | $19.01 | -80.8% | COM | 00091E109 |
| FATE | FATE THERAPEUTICS INC | 12,872,946 | $12,649 | 0.9% | $13.12 | -90.9% | COM | 31189P102 |
| SLN | SILENCE THERAPEUTICS PLC | 2,164,777 | $13,162 | 1.0% | $18.53 | — | ADS | 82686Q101 |
| ATRA | ATARA BIOTHERAPEUTICS INC | 441,701 | $7,990 | 0.6% | $15.04 | -0.7% | COM NEW | 046513206 |
| — | REPARE THERAPEUTICS INC | 1,586,174 | $4,124 | 0.3% | $30.51 | — | COM | 760273102 |
| KLRS | KALARIS THERAPEUTICS INC | 82,955 | $700 | 0.1% | $9.79 | -34.7% | COM | 482929106 |